DSNKY (Daiichinkyo Co) Moat Score: 7/10 (As of Jul. 07, 2026)


DSNKY Daiichi Sankyo Co Ltd DSNKY
71 GF Score
Price $16.82
GF Value $37.93
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Daiichinkyo Co Moat Score?

Daiichinkyo Co DSNKY -1.98% 71 Moat Score is 7 as of Jul. 07, 2026. GuruFocus rates DSNKY with a GF Score™ of 71/100 and a GF Value™ of $37.93 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 1,032 Drug Manufacturers companies, Daiichinkyo Co ranks better than 98.64% on this metric.

Daiichinkyo Co has the Moat Score of 7, which implies that the company might have Wide Moat - Entry-level wide moat, clearly possessing durable advantages.

Daiichinkyo Co has Wide Moat: Daiichi Sankyo Co Ltd has a strong portfolio of valuable patents and significant R&D capabilities. It benefits from regulatory barriers in the pharmaceutical industry and has a strong brand with customer loyalty. Its market leadership and durable cost advantages support a wide moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Daiichinkyo Co might have Wide Moat - Entry-level wide moat, clearly possessing durable advantages.

Daiichinkyo Co  (OTCPK:DSNKY) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Daiichinkyo Co Moat Score Related Terms

DSNKY vs LLY, JNJ, ABBV: Moat Score Comparison

For the Drug Manufacturers - General subindustry, Daiichinkyo Co's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Daiichinkyo Co Moat Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Daiichinkyo Co's Moat Score distribution charts can be found below:

* The bar in red indicates where Daiichinkyo Co's Moat Score falls into.


DSNKY
71GF Score
Daiichi Sankyo Co Ltd DSNKY
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 7 mean?
Daiichinkyo Co (DSNKY) has a Moat Score of 7 as of Jul. 07, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Daiichinkyo Co ranks #14 out of 1032 companies in the Drug Manufacturers industry, placing it in the top 1.4%.
Is Daiichinkyo Co's Moat Score too high?
Daiichinkyo Co's current Moat Score is 7. Based on the distribution chart, Daiichinkyo Co ranks #14 out of 1032 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Daiichinkyo Co has a GF Score™ of 71/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Daiichinkyo Co's Moat Score compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Daiichinkyo Co ranks #14 out of 1032 companies for Moat Score. This places Daiichinkyo Co in the top 1% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Drug Manufacturers company?
A good Moat Score depends on the Drug Manufacturers industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Daiichinkyo Co's current Moat Score is 7. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daiichinkyo Co stock overvalued right now?
Based on GuruFocus' analysis, Daiichinkyo Co (DSNKY) is currently considered Significantly Undervalued. The stock's GF Value™ is $37.93, compared to a current price of $16.82 — trading 55.7% below its estimated fair value. The current Moat Score is 7. Daiichinkyo Co's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Daiichinkyo Co (DSNKY), the current Moat Score is 7 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Daiichinkyo Co (DSNKY) Overvalued in 2026?

Based on GuruFocus' analysis, Daiichinkyo Co stock appears to be undervalued. The current stock price of $16.82 is trading 55.7% below its estimated GF Value™ of $37.93. GuruFocus considers Daiichinkyo Co to be Significantly Undervalued.

Key valuation signals for DSNKY:

  • Moat Score: 7
  • GF Value™: $37.93 vs. price of $16.82 (55.7% below fair value)
  • GF Score™: 71/100 with 3 warning signs

No single metric tells the full story. See the DSNKY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Daiichinkyo Co Business Description

Address 3-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, JPN, 103-8426
Daiichi Sankyo was established by the merger of Daiichi Pharmaceuticals and Sankyo in 2005. As of 2024, approximately one quarter of revenue comes from its Japan businesses, which will shrink in the future as the company expands its global footprint. Its primary growth driver is its leading platform of antibody drug conjugates, or ADCs. Its lead ADCs are Enhertu (HER2), Datroway (TROP2), I-DXd (B7-H3), HER3-DXd (HER3), and R-DXd (CDH6). Enhertu was first approved in the US in December 2019, and Datroway was first approved in January 2025.
71GF Score

Get the complete analysis for DSNKY

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.82
Price
$37.93
GF Value